Natera

Natera Liabilities

The The Liabilities of Natera (NTRA) as of Nov 22, 2026 is 795.62 M USD. In the previous year, The Liabilities was 465.32 M USD — a change of 70.99% (higher).

Liabilities

795.62 MUSD

YoY

70.99%

Last updated:

In 2025, Natera's total liabilities amounted to 795.62 M USD, a 70.99% difference from the 465.32 M USD total liabilities in the previous year.

The Natera Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
236.01 M USD
Jan 1, 2019
303.95 M USD
Jan 1, 2020
445.92 M USD
Jan 1, 2021
583.18 M USD
Jan 1, 2022
688.73 M USD
Jan 1, 2023
676.37 M USD
Jan 1, 2024
465.32 M USD
Jan 1, 2025
795.62 M USD
The Natera Liabilities history
YEARLiabilitiesYoY
795.62 MUSD+70.99%
465.32 MUSD-31.20%
676.37 MUSD-1.79%
688.73 MUSD+18.10%
583.18 MUSD+30.78%
445.92 MUSD+46.71%
303.95 MUSD+28.79%
236.01 MUSD+24.74%
189.20 MUSD+81.56%
104.20 MUSD+29.49%
80.48 MUSD-72.72%
294.96 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Natera Stock analysis

What does Natera do? Natera Inc. is an American company headquartered in San Carlos, California. It was founded in 2004 by Matthew Rabinowitz and has been listed on the NASDAQ under the ticker symbol "NTRA" since 2015. The company is a leading provider of diagnostic tests and analyses and specializes in genetic analysis and diagnostic technologies. Natera specializes in tests for various medical areas, particularly in oncology diagnostics. The company's vision is to improve the quality of life for millions of people worldwide by offering innovative diagnostic tests to detect diseases early and ensure optimal treatment. Natera offers a wide range of products tailored to the needs of consumers, physicians, and scientists. The company operates in three business areas: 1) Women's Health: Natera offers tests for women and couples to determine the risk of hereditary diseases. For example, the company offers a test that allows analysis of fetal DNA from the mother's blood, allowing detection of genetic abnormalities in the fetus before birth. Additionally, Natera offers the Panorama test, which provides tests for genetic anomalies in unborn babies that can be used to determine the risk for chromosomal abnormalities and genetic mutations. 2) Oncology: In the field of oncology, Natera offers a wide range of diagnostic tests targeting developments and trends in cancer research. The tests aim to enable accurate diagnosis and prognosis, as well as provide individualized treatment for each patient. The company offers tests that assess the current tumor growth and metastatic potential, enable determination of tumor burden in cells, and provide tests for specific mutations required for determining optimal treatment. 3) Genomic Analysis: In the field of genomic analysis, Natera offers a broad range of tests available to researchers and scientists. This includes genetic variants and biological mechanisms that cause diseases. The company is also committed to developing its tests through artificial intelligence (AI) and machine learning. The goal is to provide more accurate and faster results, improve clinical decisions, and advance research and development of new diagnostics. Conclusion: Natera is a leading company in the field of diagnostic tests and analyses in the field of genomic analysis. The company has a long history of research and development of innovative product solutions for the medical community. One important focus of the company is to improve women's health and be able to detect risks for genetic diseases early; the other focus is on oncology diagnostic tools to determine optimal treatment for cancer patients. The company is constantly striving to further develop its tests and integrate new research findings and technologies to support the medical science community. Natera is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Natera's Liabilities

Natera's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Natera's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Natera's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Natera's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Natera’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Natera stock

The Liabilities of Natera is 795.62 M USD in 2025.

The Liabilities of Natera changed from 465.32 M USD to 795.62 M USD, representing a 70.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Natera since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Natera historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Natera

All Key Metrics — Natera